Table 1 Multi-vendor, multi-center database (n = 703) description by pathology, gender and age

Yale (n = 150)

Siemens (n = 150)

Yale New Haven Hospital (USA)

Arrythmia

63

18

54 ± 15

Pulmonary arterial hypertension^†

25

18

62 ± 14

Hypertrophic cardiomyopathy

14

4

51 ± 15

Sarcoid

6

5

52 ± 15

Myocarditis

6

3

41 ± 15

Myocardial infarction

4

1

43 ± 13

Other cardiac diseases

13

7

51 ± 13

Healthy adult volunteers

19

5

51 ± 14

Lund (n = 553)

Philips (n = 419)

CHILL-MI and MITOCARE* (4 centers, 3 countries)

ST-elevation myocardial infarction

57

14

53 ± 19

Skåne University Hospital (Sweden)

Chronic heart failure

130

28

60 ± 13

Heart failure with reduced ejection fraction

54

11

68 ± 9

Atrial septal defect

19

13

50 ± 18

Endurance athletes

39

11

39 ± 18

Healthy adolescent volunteers

39

21

13 ± 2

Healthy young adult volunteers^†

57

25

26 ± 5

Healthy senior adult volunteers

24

10

53 ± 8

Siemens (n = 100)

CHILL-MI and MITOCARE* (13 centers, 4 countries)

ST-elevation myocardial infarction

74

19

50 ± 2

Skåne University Hospital (Sweden)

Healthy young adult volunteers

7

2

27 ± 2

Healthy senior adult volunteers

19

6

56 ± 5

General Electric (n = 34)

MITOCARE* (2 centers, 2 countries)

ST-elevation myocardial infarction

34

5

62 ± 9